Journal
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
Volume 107, Issue -, Pages 112-120Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/j.ijbiomac.2017.08.154
Keywords
Rhamnogalacturonan I (RG-I) pectic polysaccharide; Lonicera japonica Thunb.; A beta(42) aggregation; Neuritogenesis; Alzheimer's disease
Funding
- National Natural Science Foundation of China (NSFC) [31230022]
- Shanghai Outstanding Academic Leaders Program [16XD1404500]
- National Natural Science Foundation of China [31400690]
- Shanghai Science Research Program [13ZR1447500]
Ask authors/readers for more resources
Pectin is a class of complex polysaccharides and recognized for its potential bioactivities. In this study, we showed that a pectic polysaccharide, LFA03-a, was extracted from Lonicera japonica Thunb. flowers and purified with DEAE-celluiose and Sephacryl S-100HR. LFA03-a was composed of rhamnose, arabinose, galactose and galacturonic acid in the molar ratio of 18.1:25.3:36.8:19.5. Its structure was determined to possess a rhamnogalacturonan I (RG-I) backbone consisting of alpha-L-1,2-Rhap and alpha-D-1,4-GalAp disaccharide repeating unit, substituted at 0-4 of L-rhamnose. The side chain was involved with beta-D-1,4-Galp, beta-D-1,3-Galp, beta-D-1,3,6-Galp and branched alpha-L-1,5-Araf. Fluorescence spectroscopic analysis with thioflavine T (ThT) and atomic force microscopy (AFM) results showed that LFA03-a inhibited A beta(42) aggregation in a dose dependent manner and impeded A beta(42) oligomerization and fibril formation. In addition, LFA03-a mildly induced the differentiation of PC12 cells and promoted neuritogenesis.The results suggested that pectin LFA03-a might be a potential targeted therapeutic drug for Alzheimer's disease. (C) 2017 Published by Elsevier B.V.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available